Back to Search
Start Over
Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure, metabolic profile and neurohumoral axis in hypertensive women at reproductive age.
- Source :
-
European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2014 Nov; Vol. 182, pp. 113-7. Date of Electronic Publication: 2014 Sep 16. - Publication Year :
- 2014
-
Abstract
- Unlabelled: The use of combined oral contraceptives is widespread among hypertensive women despite being associated with increased cardiovascular risk. Contraceptives containing drospirenone, which has antimineralocorticoid properties, may have a positive or neutral effect on neurohumoral activation and metabolic homeostasis of hypertensive women at reproductive age.<br />Objectives: To evaluate the effect of combined oral contraceptive containing drospirenone+ethinylestradiol on the systemic blood pressure, metabolic variables and neurohumoral axis in hypertensive women in reproductive age.<br />Design: Prospective controlled trial with 56 hypertensive women allocated in two groups: 30 volunteers under oral combined contraceptive use and 26 volunteers using non-hormonal contraceptive methods. Subjects were tested before the introduction of the contraceptive method and 6 months after its use. For data acquisition, we used continuous non-invasive beat-to-beat blood pressure curve recordings and, for the biochemical and hormonal analyses two blood samples were obtained. Student's t test was used to determine differences between groups and moments and p<0.05 was considered statistically significant.<br />Results: Comparing antropometric and blood pressure measurements, cardiac sympatho-vagal modulation, baroreceptor sensitivity, metabolic and neurohumoral axis variables between baseline and after 6 months, no significant difference was detected in each group or between groups. Except serum triglyceride levels which increased in the group of women using EE+DRSP after 6 months of use.<br />Conclusion: A contraceptive containing 20 mcg of ethinyl estradiol and 3 mg of drospirenone causes no significant changes in clinical and autonomic parameters, metabolic variables and neurohumoral axis of hypertensive women.<br /> (Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.)
- Subjects :
- Adult
Aldosterone blood
Antihypertensive Agents therapeutic use
Baroreflex drug effects
Body Mass Index
Contraceptives, Oral, Combined chemistry
Electrolytes blood
Female
Heart Rate drug effects
Homeostasis drug effects
Humans
Hypertension drug therapy
Hypertension physiopathology
Prospective Studies
Triglycerides blood
Young Adult
Androstenes pharmacology
Blood Pressure drug effects
Contraceptives, Oral, Combined pharmacology
Ethinyl Estradiol pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1872-7654
- Volume :
- 182
- Database :
- MEDLINE
- Journal :
- European journal of obstetrics, gynecology, and reproductive biology
- Publication Type :
- Academic Journal
- Accession number :
- 25268778
- Full Text :
- https://doi.org/10.1016/j.ejogrb.2014.09.006